Publication | Open Access

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial

Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyPathologyImmune Checkpoint InhibitorIntensified ChemotherapyImmunotherapyOncologyRadiation OncologyPhase 3